| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 04/25/2013 | US20130101690 Supplements and methods of supplementation |
| 04/25/2013 | US20130101680 Radiotherapy enhancer |
| 04/25/2013 | US20130101678 Compositions and Methods for Treating Vaginal Infections and Pathogenic Vaginal Biofilms |
| 04/25/2013 | US20130101664 Muc1 ligand traps for use in treating cancers |
| 04/25/2013 | US20130101657 Angiogenesis inhibitors |
| 04/25/2013 | US20130101650 Use of dihydrodehydrodiisoeugenol and preparations comprising dihydrodehydrodiisoeugenol |
| 04/25/2013 | US20130101641 Periodontal Regeneration Composition and Method of Using Same |
| 04/25/2013 | US20130101616 Compositions of botanical extracts for cancer therapy |
| 04/25/2013 | US20130101611 Citrullination of human peptidylarginine deiminase 4 (pad-4) regulates its function and immunogenicity |
| 04/25/2013 | US20130101608 Human antibody drug conjugates against tissue factor |
| 04/25/2013 | US20130101598 Antagonists of il-6 to prevent or treat thrombosis |
| 04/25/2013 | US20130101597 Modulation of nk cell antigen specific effector activity by modulation of cxcr6 (cd186) |
| 04/25/2013 | US20130101595 Antibodies that bind il-18 and methods of inhibiting il-18 activity |
| 04/25/2013 | US20130101564 Method for preparing dermis tissue cells aggregation and uses thereof |
| 04/25/2013 | US20130101552 Methods and compositions for contributing to the treatment of cancers |
| 04/25/2013 | US20130101550 Product and method for permeabilisation of tumor vasculature |
| 04/25/2013 | US20130101514 Compositions and methods for treating nephropathy |
| 04/25/2013 | US20130101510 Methods of treating parkinson's disease using viral vectors |
| 04/25/2013 | US20130101506 Compositions comprising nucleic acid aptamers |
| 04/24/2013 | EP2583691A1 Agent for treating renal fibrosis |
| 04/24/2013 | EP2583685A1 Method of administering and using VEGF inhibitors for the treatment of human cancer |
| 04/24/2013 | EP2583680A2 Mono (PSI-7977) or combination treatment of DAAs for use in treating HCV |
| 04/24/2013 | EP2583678A2 Small molecule immunopotentiators and assays for their detection |
| 04/24/2013 | EP2583675A1 Use of dipeptidylpeptidase inhibitors to regulate glucose metabolism |
| 04/24/2013 | EP2582832A1 Methods and pharmaceutical compositions for treating the animal central nervous system for psychiatric disorders |
| 04/24/2013 | EP2582725A2 Anti-dr4 agonist antibodies |
| 04/24/2013 | EP2582683A1 Treatment of gout and hyperuricemia |
| 04/24/2013 | EP2582682A1 Methods of treating lung disease |
| 04/24/2013 | EP2582393A1 Dose selection of adjuvanted synthetic nanocarriers |
| 04/24/2013 | EP2582369A1 An antitumoral combination comprising ombrabulin, a taxane derivative and a platinum derivative |
| 04/24/2013 | EP2582366A1 Pharmaceutical combination for the treatment of pain |
| 04/24/2013 | EP2582355A2 Methods and compositions for promoting hair growth |
| 04/24/2013 | CN1935141B Use of descarboethoxyloratadine or its pharmaceutical salts in preparing medicine for treating urticaria |
| 04/24/2013 | CN1869061B Peptidomimetic protease inhibitors |
| 04/24/2013 | CN103068403A Method and composition for treating, preventing and diagnosing cancer containing cancer stem cells or derived therefrom |
| 04/24/2013 | CN103068402A Composition for regeneratng normal tissue from fibrotic tissue |
| 04/24/2013 | CN103068364A Preservative free bimatoprost and timolol solutions |
| 04/24/2013 | CN103055322A Targeted sustained release medicine carrying nanoparticle and preparation method thereof |
| 04/24/2013 | CN103055316A Pharmaceutically acceptable solubilizing composition and pharmaceutical dosage form containing same |
| 04/24/2013 | CN103055314A 雌激素的应用 Application of estrogen |
| 04/24/2013 | CN103055313A Methods and related compositions for treating or preventing obesity, insulin resistance disorders, and mitochondrial-associated disorders |
| 04/24/2013 | CN103054871A Antitumor effect fortifier, antitumor agent and method of therapy for cancer |
| 04/24/2013 | CN103054833A A formula of an antimicrobial oil emulsion microcapsule for veterinary use |
| 04/24/2013 | CN103054794A Insoluble medicine gel composition and preparation method for same |
| 04/24/2013 | CN102488908B Flushing fluid for electrocision and application of same |
| 04/24/2013 | CN102337268B Human CTRP4 gene, its coding protein and their application |
| 04/24/2013 | CN102274515B Medicinal composition containing montelukast and statins medicament |
| 04/24/2013 | CN101983051B Preparation for preventing or ameliorating wrinkles, to be taken orally, through injection, or through external application to skin, and cosmetic method |
| 04/24/2013 | CN101861387B Novel bacteriophage and antibacterial composition containing the same |
| 04/24/2013 | CN101784287B Aqueous composition |
| 04/24/2013 | CN101730546B Adjuvant combinations of nkt activator, cd40 agonist, and optional antigen, the use through inducing synergistic cellular immunity |
| 04/24/2013 | CN101643789B RNA interference mediating small RNA molecules |
| 04/24/2013 | CN101516374B Histone deacetylase inhibitors with combined activity on class-i and class-iib histone deacetylases in combination with proteasome inhibitors |
| 04/24/2013 | CN101300346B Novel biological substance nesfatin and its related substances and uses thereof |
| 04/23/2013 | US8426468 Use of medium chain triglycerides for the treatment and prevention of alzheimer'S disease and other diseases resulting from reduced neuronal metabolism |
| 04/23/2013 | US8426426 Gyrase inhibitors and uses thereof |
| 04/23/2013 | US8426423 e.g. 7-{4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butoxyl}-3,4-dihydrocarbostyril; serotonin receptor agonist; antidepressant, anxilytic agent; psychological disorders; autism, Down's syndrome, attention deficit hyper-activity disorder (ADHD), Alzheimer's disease, Parkinson's disease , |
| 04/23/2013 | US8426410 Compounds, formulations, and methods for treating or preventing inflammatory skin disorders |
| 04/23/2013 | US8426198 In vitro differentiated cell and human embryonic stem cell population |
| 04/23/2013 | US8426147 RORS as modifiers of the p21 pathway and methods of use |
| 04/23/2013 | US8425939 Remedy |
| 04/23/2013 | US8425921 Lipid raft, caveolin protein, and caveolar function modulation compounds and associated synthetic and therapeutic methods |
| 04/23/2013 | US8425915 Nanoparticles for providing immune responses against infectious agents |
| 04/23/2013 | US8425908 Treatment with anti-ErbB2 antibodies |
| 04/23/2013 | CA2581125C Modified poly(ethylene oxide-amino acid) copolymer, micelle preparation, and anticancer agent containing the same |
| 04/23/2013 | CA2539277C Aminoalkanol derivatives |
| 04/23/2013 | CA2516331C Combination therapy using glycosaminoglycans and therapeutic agents for the treatment of respiratory disorders |
| 04/23/2013 | CA2515761C Use of artemisinin for treating tumors induced by oncogenic viruses and for treating viral infections |
| 04/23/2013 | CA2436245C Medicament for protection in radiotherapy |
| 04/23/2013 | CA2381125C Ligands for use in therapeutic compositions for the treatment of hemostasis disorders |
| 04/18/2013 | WO2013055888A2 Recombinant human naglu protein and uses thereof |
| 04/18/2013 | WO2013055874A2 Uses for and article of manufacture including her2 dimerization inhibitor pertuzumab |
| 04/18/2013 | WO2013054111A1 Improved sperm function/activity |
| 04/18/2013 | WO2013054002A1 Prevention and diagnosis of visceral fat |
| 04/18/2013 | WO2013054001A1 Raising and diagnosing of serotonin level |
| 04/18/2013 | WO2013053833A1 2 - carboxamide cycloamino urea derivatives in combination with hsp90 inhibitors for the treatment of proliferative diseases |
| 04/18/2013 | WO2013053775A1 Combination medicament comprising il-12 and an agent for blockade of t-cell inhibitory molecules for tumour therapy |
| 04/18/2013 | WO2013053751A1 Compositions for the treatment of rheumatoid arthritis and methods of using same |
| 04/18/2013 | WO2013022927A3 Treatment of uterine leiomyomata |
| 04/18/2013 | US20130096185 INACTIVATION OF miR-34a BY ABERRANT CpG METHYLATION IN CANCER |
| 04/18/2013 | US20130096181 Methods of using scd1 antagonists |
| 04/18/2013 | US20130096168 Substituted carbamoylmethylamino acetic acid derivatives as novel NEP inhibitors |
| 04/18/2013 | US20130096162 Dual-acting antihypertensive agents |
| 04/18/2013 | US20130096149 Heteroaryl compounds and compositions as protein kinase inhibitors |
| 04/18/2013 | US20130096143 N-acyl amino acid derivatives for treating skin conditions such as cellulite |
| 04/18/2013 | US20130096142 Methods for healthy aging |
| 04/18/2013 | US20130096139 Compounds Useful as Inhibitors of ATR Kinase |
| 04/18/2013 | US20130096132 Azaadamantane derivatives and methods of use |
| 04/18/2013 | US20130096128 Pyrazole compounds useful as protein kinase inhibitors |
| 04/18/2013 | US20130096127 Substituted aminopropionic derivatives as neprilysin inhibitors |
| 04/18/2013 | US20130096110 Pyrazolopyridine, Pyrazolopyrazine, Pyrazolopyrimidine, Pyrazolothiophene and Pyrazolothiazole Compounds as MGLUR4 Allosteric Potentiators, Compositions, and Methods of Treating Neurological Dysfunction |
| 04/18/2013 | US20130096106 Compounds and methods for the treatment or prevention of flavivirus infections |
| 04/18/2013 | US20130096105 ArylSulfonamide Based Matrix Metalloprotease Inhibitors |
| 04/18/2013 | US20130096095 Small-molecule inhibitors of the androgen receptor |
| 04/18/2013 | US20130096093 Compositions and methods of treatment for inflammatory diseases |
| 04/18/2013 | US20130096084 Novel heterocyclic compounds as erk inhbitors |
| 04/18/2013 | US20130096068 Combination therapy with a proteasome inhibitor and a gallium complex |
| 04/18/2013 | US20130096066 Pharmaceutical formulation for reducing pain |
| 04/18/2013 | US20130096056 Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors |
| 04/18/2013 | US20130096054 Latent human immunodeficiency virus reactiviation |